BUND FINANCE › Stocks › PHG
Koninklijke Philips N.V. (PHG)
NYSE · Stock price, chart and technical analysis
Data from Financial Modeling Prep · Nov 18, 2026, 4:00 PM New York time · may be delayed
Key stats
Quick technical read
- Price is +13.25% above its 50-day average.
- It is +9.39% above its 200-day average (long-term uptrend).
- It sits at 63% of its 52-week range (0% = low, 100% = high).
This describes price action; it is not a recommendation. The app also calculates RSI, MACD, the entry setup and 30+ indicators. How we calculate it
Fundamentals Annual
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | EUR 17.2B | EUR 17.8B | EUR 18.2B | EUR 18.0B | EUR 17.8B |
| Net income | EUR 3.3B | −EUR 1.6B | −EUR 466.0M | −EUR 702.0M | EUR 895.0M |
| EPS (diluted) | 0.64 | -1.68 | -0.49 | -0.75 | 0.93 |
| Gross margin | 41.8% | 40.4% | 41.0% | 43.1% | 45.2% |
| Operating margin | 3.2% | -8.6% | -0.6% | 2.9% | 8.0% |
| Net margin | 19.4% | -9.0% | -2.6% | -3.9% | 5.0% |
| Free cash flow | EUR 866.0M | −EUR 979.0M | EUR 1.6B | EUR 893.0M | EUR 893.0M |
| Total debt | EUR 6.0B | EUR 7.3B | EUR 7.3B | EUR 7.5B | EUR 8.1B |
| Cash | EUR 2.3B | EUR 1.2B | EUR 1.9B | EUR 2.4B | EUR 2.8B |
Compound annual growth: revenue 1.0% · net income -27.9% (4 years).
Valuation: today, its history and its sector
| Today | 5-year average | Sector median (Healthcare) | |
|---|---|---|---|
| P/E | — | 34.5x | 27.1x |
| EV / EBITDA | — | 46.9x | 16.5x |
| Operating margin | 10.5% | — | 3.6% |
| Net margin | 5.4% | — | -0.0% |
| Debt / equity | 1.42 | — | 0.58 |
Source: annual financial statements from Financial Modeling Prep. “Today” uses the current price and the last 4 quarters. The sector median uses U.S. companies above US$300M market cap. A multiple above or below its history or sector is not a recommendation. The company reports in another currency: amounts are shown in that currency.
About Koninklijke Philips N.V.
Koninklijke Philips N.V. operates as a leading global healthcare technology enterprise with a presence across North America and numerous international markets. Its operations are organized into three primary divisions: Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses. Within the Diagnosis & Treatment segment, Philips offers advanced diagnostic imaging technologies, including magnetic resonance (MRI), computed tomography (CT), X-ray systems, and innovative detector-based spectral CT solutions, alongside molecular and hybrid imaging for nuclear medicine. The company also provides integrated interventional systems and comprehensive echography (ultrasou…
Other stocks on BUND FINANCE
Not financial advice. BUND FINANCE publishes general information for educational purposes. Investing involves risk, including loss of capital. Legal notice